-- マグナ・テラ・ミネラルズ（MTT.V）は木曜日、ニューファンドランド島西部のシェルバード金プロジェクトを取得したと発表した。 このプロジェクトは、地域規模のドゥーサーズ・バレー断層帯（DVFZ）の延長線上に位置し、総面積30,650ヘクタールの5つの鉱業権から構成されている。 プロジェクトは、地域規模のドゥーサーズ・バレー断層帯とその関連断層分岐の35キロメートルにわたる範囲をカバーしている。 「過去にこの鉱区で行われた初期段階の貴金属探査では、最大2.33g/tの金を含む有望なサンプル結果が得られたものの、その後の調査は行われなかった。当社チームは、この春に重要な探査作業を完了できることを大変嬉しく思っている」と、最高経営責任者（CEO）のルー・ローリック氏は述べた。 同社の株価は、トロント証券取引所ベンチャー市場で0.005ドル高の0.165ドルで取引されている。
Price: $0.17, Change: $+0.01, Percent Change: +3.13%
Galloper Gold (BOOM.CN) on Thursday said it plans to begin a 2026 drilling program at Glover Island targeting new high-grade gold targets in the Lunch Pond South Extension (LPSE) gold deposit.The company also plans regional exploration drilling, particularly at Lucky Smoke.An updated geological modelling and engineering exercise resulted in the recently released and increased LPSE Mineral Resource Estimate (MRE), said the company and added that the 2026 drilling program will follow-up and build on this "momentum."The 2026 drilling program is expected to include up to 7,000 meters of diamond drilling in over 25 boreholes. Drilling will target along-strike and down-dip continuity of the LPSE and Lucky Smoke gold deposits within the Kettle Pond formation, the company added."Galloper Gold Corp. has been comprehensively evaluating the Kettle Pond Formation gold mineralized trend with historical data, and, as a result of this, we have recently released an updated MRE for the LPSE deposit," said chief executive Hratch Jabrayan. "This effort has resulted in a new understanding of the geological architecture of the property and has built targeting for additional gold mineralization intercepts."Shares of the company were last seen unchanged at $0.10 on the Canadian Securities Exchange.
United Therapeutics (UTHR) still has a stronger long-term growth path despite a soft Q1, helped by Tyvaso durability, possible idiopathic pulmonary fibrosis expansion, TreSMI filing plans, and future upside from ralinepag, RBC Capital Markets said in a note emailed Thursday.The investment firm said Tyvaso revenue missed estimates in Q1, but the firm expects the franchise to return to growth after weather issues and specialty pharmacy delays subside.IPF could become the company's next major growth driver, with a supplemental application still planned for this summer and other faster approval paths under review, RBC said.TreSMI remains on track for a US Food and Drug Administration filing in pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease by year's end, which could help United Therapeutics defend its position in inhaled treprostinil, according to the note.Ralinepag Dry Powder Inhalation could add longer-term upside because once daily dosing may help the company compete better in pulmonary hypertension and related lung disease markets, RBC added.RBC lowered its price target for United Therapeutics to $701 from $707 while keeping its outperform rating.Price: $576.22, Change: $-20.55, Percent Change: -3.44%
Klaviyo (KVYO) said Thursday it has expanded its integration with Anthropic to provide new agentic marketing workflows to the Claude AI model.Customers will be able to securely access and generate outputs from their customer and performance data through the connection of Klaviyo's Model Context Protocol server across Claude's products, according to a statement.Price: $15.84, Change: $+0.03, Percent Change: +0.18%